Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $204.1 million versus the consensus estimate of $204.04 million.

Expects FY 2017 sales to grow 1-3% on constant currency basis

For earnings history and earnings-related data on Conmed (CNMD) click here.